Brief Report: Clinical Outcomes of Young Black Men Receiving HIV Medical Care in the United States, 2009-2014.

Pranesh Chowdhury, Linda Beer, R Luke Shouse, Heather Bradley, Medical Monitoring Project
Author Information
  1. Pranesh Chowdhury: Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA.

Abstract

BACKGROUND: More than one-quarter of 2016 HIV diagnoses among blacks in the United States occurred among persons aged 15-24 years, and three-quarters were among men. Although the prevalence of viral suppression in all tests in the past 12 months (durable viral suppression) among persons receiving HIV care increased from 58% to 68% during 2009-2013, we do not know whether this same improvement was observed among young black men receiving care.
METHODS: We analyzed the 2009-2014 Medical Monitoring Project data collected from 336 black men aged 18-24 years. We estimated the proportion of young black men receiving HIV care who were prescribed antiretroviral therapy (ART), adherent to ART, and durably virally suppressed. We assessed changes in clinical outcomes over time and their association with patient characteristics, health behaviors, and depression.
RESULTS: During 2009-2014, 80% of young black men receiving HIV care were prescribed ART, 73% were adherent to ART, and 36% had durable viral suppression. There was no significant change in viral suppression over this period. ART prescription and durable viral suppression were significantly higher among those receiving the Ryan White HIV/AIDS Program assistance compared with those who did not. Durable viral suppression was significantly lower among those who used drugs compared with those who did not.
CONCLUSIONS: Viral suppression among young black men during 2009-2014 was lower than that among the overall population receiving HIV care in 2013 (36% vs. 68%). Increasing viral suppression is essential to improve health and reduce HIV transmissions in this key population.

References

  1. MMWR Morb Mortal Wkly Rep. 2016 Sep 23;65(37):1004-1007 [PMID: 27657489]
  2. P T. 2015 Jan;40(1):44-55 [PMID: 25628507]
  3. J Acquir Immune Defic Syndr. 2016 Dec 1;73(4):446-453 [PMID: 27391389]
  4. N Engl J Med. 2016 Sep 1;375(9):830-9 [PMID: 27424812]
  5. AIDS Educ Prev. 2015 Feb;27(1):58-71 [PMID: 25646730]
  6. MMWR Morb Mortal Wkly Rep. 2018 Feb 02;67(4):113-118 [PMID: 29389918]
  7. Ann Intern Med. 2012 Jun 5;156(11):817-33, W-284, W-285, W-286, W-287, W-288, W-289, W-290, W-291, [PMID: 22393036]
  8. J Affect Disord. 2009 Apr;114(1-3):163-73 [PMID: 18752852]
  9. J Health Psychol. 2016 Jul;21(7):1311-21 [PMID: 25293970]
  10. JAMA Intern Med. 2015 Oct;175(10):1650-9 [PMID: 26322677]
  11. AIDS. 2016 Aug 24;30(13):2117-24 [PMID: 27465279]
  12. Health Psychol. 2007 Jan;26(1):40-9 [PMID: 17209696]
  13. AIDS Behav. 2013 Jan;17(1):31-40 [PMID: 23010941]
  14. Public Health Rep. 2016 Jul-Aug;131(4):526-30 [PMID: 27453595]

Grants

  1. CC999999/Intramural CDC HHS

MeSH Term

Adolescent
Black or African American
Anti-HIV Agents
Cross-Sectional Studies
HIV Infections
Humans
Male
Treatment Outcome
United States
Viral Load
Young Adult
Assessment of Medication Adherence

Chemicals

Anti-HIV Agents

Word Cloud

Created with Highcharts 10.0.0amongsuppressionHIVviralmenreceivingcareblackARTyoung2009-2014durableUnitedStatespersonsagedyears68%Medicalprescribedadherenthealth36%significantlycomparedlowerpopulationBACKGROUND:one-quarter2016diagnosesblacksoccurred15-24three-quartersAlthoughprevalencetestspast12monthsincreased58%2009-2013knowwhetherimprovementobservedMETHODS:analyzedMonitoringProjectdatacollected33618-24estimatedproportionantiretroviraltherapydurablyvirallysuppressedassessedchangesclinicaloutcomestimeassociationpatientcharacteristicsbehaviorsdepressionRESULTS:80%73%significantchangeperiodprescriptionhigherRyanWhiteHIV/AIDSProgramassistanceDurableuseddrugsnotCONCLUSIONS:Viraloverall2013vsIncreasingessentialimprovereducetransmissionskeyBriefReport:ClinicalOutcomesYoungBlackMenReceivingCare

Similar Articles

Cited By